Back to DNLI

CONTRAVISORY INVESTMENT MANAGEMENT, INC. → DNLI

CONTRAVISORY INVESTMENT MANAGEMENT, INC. DNLI Position History

Denali Therapeutics Inc. • Healthcare

Quarters held
3
Latest value
$346K
Q3 2026
Peak value
$377K
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$277K
Q2 2026$377K
Q3 2026$346K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$346K16.7K——
Q2 2026$377K14.7K——
Q1 2026$277K14.5K——

Other funds holding DNLI

Other CONTRAVISORY INVESTMENT MANAGEMENT, INC. positions

KLAC

KLA CORP

$23.6M
TSMWF

TAIWAN SEMICONDUCTOR MANUFAC

$19.9M
TSMWF

TAIWAN SEMICONDUCTOR MANUFAC

$15.8M
APA

APA CORPORATION

$14.7M
UBS

UBS GROUP AG

$14.3M
KLAC

KLA CORP

$14.3M
TSMWF

TAIWAN SEMICONDUCTOR MANUFAC

$14M
APA

APA CORPORATION

$13.9M